Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.

<h4>Registered clinical trial</h4>[NCT03677921]; www.clinicaltrials.gov [KCT0002726]; https://cris.nih.go.kr.

Bibliographic Details
Main Authors:	Jung Min Cho, Jisuk Chae, Sa Rang Jeong, Min Jung Moon, Dong Yeob Shin, Jong Ho Lee
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0240358

id	doaj-703206df3f244721852dd56c0f246730
record_format	Article
spelling	doaj-703206df3f244721852dd56c0f2467302021-03-04T11:09:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011510e024035810.1371/journal.pone.0240358Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.Jung Min ChoJisuk ChaeSa Rang JeongMin Jung MoonDong Yeob ShinJong Ho Lee<h4>Registered clinical trial</h4>[NCT03677921]; www.clinicaltrials.gov [KCT0002726]; https://cris.nih.go.kr.https://doi.org/10.1371/journal.pone.0240358
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Jung Min Cho Jisuk Chae Sa Rang Jeong Min Jung Moon Dong Yeob Shin Jong Ho Lee
spellingShingle	Jung Min Cho Jisuk Chae Sa Rang Jeong Min Jung Moon Dong Yeob Shin Jong Ho Lee Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights. PLoS ONE
author_facet	Jung Min Cho Jisuk Chae Sa Rang Jeong Min Jung Moon Dong Yeob Shin Jong Ho Lee
author_sort	Jung Min Cho
title	Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.
title_short	Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.
title_full	Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.
title_fullStr	Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.
title_full_unstemmed	Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.
title_sort	immune activation of bio-germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: therapeutic opportunities from new insights.
publisher	Public Library of Science (PLoS)
series	PLoS ONE
issn	1932-6203
publishDate	2020-01-01
description	<h4>Registered clinical trial</h4>[NCT03677921]; www.clinicaltrials.gov [KCT0002726]; https://cris.nih.go.kr.
url	https://doi.org/10.1371/journal.pone.0240358
work_keys_str_mv	AT jungmincho immuneactivationofbiogermaniuminarandomizeddoubleblindplacebocontrolledclinicaltrialwith130humansubjectstherapeuticopportunitiesfromnewinsights AT jisukchae immuneactivationofbiogermaniuminarandomizeddoubleblindplacebocontrolledclinicaltrialwith130humansubjectstherapeuticopportunitiesfromnewinsights AT sarangjeong immuneactivationofbiogermaniuminarandomizeddoubleblindplacebocontrolledclinicaltrialwith130humansubjectstherapeuticopportunitiesfromnewinsights AT minjungmoon immuneactivationofbiogermaniuminarandomizeddoubleblindplacebocontrolledclinicaltrialwith130humansubjectstherapeuticopportunitiesfromnewinsights AT dongyeobshin immuneactivationofbiogermaniuminarandomizeddoubleblindplacebocontrolledclinicaltrialwith130humansubjectstherapeuticopportunitiesfromnewinsights AT jongholee immuneactivationofbiogermaniuminarandomizeddoubleblindplacebocontrolledclinicaltrialwith130humansubjectstherapeuticopportunitiesfromnewinsights
_version_	1714804726989586432

Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights.

Similar Items